Syros Pharmaceuticals (NASDAQ:SYRS) Now Covered by Analysts at StockNews.com
StockNews.com started coverage on shares of Syros Pharmaceuticals (NASDAQ:SYRS – Free Report) in a research note released on Sunday morning. The brokerage issued a sell rating on the stock. Syros Pharmaceuticals Trading Down 1.7 % Syros Pharmaceuticals stock opened at $0.02 on Friday. The stock has a market cap of $638,601.60, a P/E ratio of […]
